Berkeley Limketkai, MD, PhD, Joins UCLA Center for Inflammatory Bowel Diseases - April 2019
Dr. Limketkai earned his medical degree at the University of Cincinnati, where he was inducted into the Alpha Omega Alpha honor society. He subsequently completed his internal medicine residency, gastroenterology fellowship, and PhD education at Johns Hopkins University. Given his primary clinical and research interests in inflammatory bowel diseases (IBD) and nutrition, Dr. Limketkai pursued advanced training as the Theodore M. Bayless Fellow in Inflammatory Bowel Diseases at Johns Hopkins University and clinical nutrition training through the Nestlé Nutrition Institute. His doctoral dissertation explored the role of vitamin D in IBD pathogenesis and severity.
Prior to joining UCLA, Dr. Limketkai served on the clinical faculty at Stanford University and as IBD physician lead at the VA Palo Alto Health Care System. At both institutions, he led a dedicated IBD team that specialized in the care of patients with simple IBD to the most complex cases, including those refractory to medical therapies and those who develop intestinal failure. He also spearheaded the Gastrointestinal Nutrition Program and initiated the Fecal Microbiota Transplantation (FMT) Program at Stanford.
At UCLA, Dr. Limketkai and colleagues are working to further the Center for Inflammatory Bowel Diseases’ outstanding patient care, high impact research and education. Their philosophy of care centers around the uniqueness of each IBD patient, addressing their multi-disciplinary and personalized needs.
As director of IBD clinical research, Dr. Limketkai strongly believes in exploiting the synergy between clinical care and research. He is keenly interested in studying microbiome manipulation as clinical therapy, including the use of prebiotics, probiotics and dietary interventions. His clinical team often combines targeted medical and nutritional strategies to optimize clinical outcomes, and their publication record reflects their expertise in the application of these burgeoning therapies for IBD. There are several planned clinical studies of nutritional and/or plant-based therapies in IBD on the horizon.
Dr. Limketkai’s other research arm involves large data analyses of clinical outcomes and health services utilization. The primary goal of this endeavor is to better understand the factors that drive favorable or unfavorable outcomes in IBD. Through our multi-institution collaboration, he hopes to generate data that will help shape and improve the future care of IBD patients.
IBD Research Expands to Include Brain-Gut-Microbiome - June 2018
The Crohn’s and Colitis Foundation of America Inc. awarded Emeran A. Mayer, MD, director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience (CNSR), a three-year grant, with an annual budget of $300,000, to study “brain-gut-microbiome signatures of stress-related IBD symptom flares.” This is the first collaborative effort between Jonathan Jacobs, MD, PhD, Jenny Sauk, MD and CNSR focusing on IBD patients.
Your Guide to Tracking Crohn’s Symptoms - February 2018
Jenny Sauk, MD, health sciences assistant clinical professor of medicine in the Vatche and Tamar Manoukian Division of Digestive Diseases at the David Geffen School of Medicine at UCLA, was featured Feb. 6 in an Everyday Health article on how to be aware of Crohn's disease symptoms early and often.
Aria Zand, MD Awarded the ECCO-IOIBD Fellowship
The International Organization for the Study of Inflammatory Bowel Disease (IOIBD) and the European Crohn’s and Colitis Organisation (ECCO) offer an exceptional, collaborative ECCO-IOIBD Fellowship. Its aim is to encourage and help individuals in their career and promote innovative scientific exchange in the area of inflammatory bowel Diseases (IBD) between Europe and other continents.
This highly prestigious award has been awarded to Dr. Aria Zand, the division’s current Melvin & Bren Simon GI Quality Improvement Program Scholar, and provides him with the opportunity to collaborate with the Department of Applied Mathematics to research precision medicine for IBD using advanced machine learning. The research will be performed at the UCLA Center for Inflammatory Bowel Diseases under the supervision of Dr. Daniel Hommes.
vQ Presented at Stanford Medicine X - September 2015
UCLA Division of Digestive Disease's has been invited to speak at one of the most innovative stages in global healthcare: Stanford Medicine X. This two-day educational event, September 23-24, 2015, will focus on the future of medical education in the new Millennium, the role technology and networked intelligence might play in driving educational innovation, the new challenges facing health care education in the new Millennium, as well as the need to change the culture of medical education to be more patient-centered, participatory and patient-safety-focused. Daniel Hommes, MD, PhD, will speak on "Providing Value @ Your Fingertips: Integrated Care in Your Back Pocket."
Beyond the Scope - Vital Role of IBD Nurses - Spring 2015
UCLA Center for IBD takes pride in having a staff of dedicated nurses specifically for IBD patients. The center's progressive value-based approach to chronic disease management is achieved by the nurses regular communication with patients in person, telephone, or a secure web-based or mobile communication platform.
Find Your Match: Health Snacks for Ulcerative Colitis - March 2015
Nancee Jaffe, MS, RD, registered dietician, was credited in this EveryDayHealth article.
UCLA Center for Inflammatory Bowel Diseases' Wellness Program Build-out Wins Re-Imaging and Transforming the Patient Experience Contest - May 2014
In May 2014, UCLA's Institute for Innovation in Health team launched the Re-Imaging and Transforming the Patient Experience contest. They called for teams who had innovative ideas that reimagine the status quo for patient experience by encouraging patients to take a greater role in managing their health.
Program Description: Expanding the Wellness Program of the vQ coordinated care model with smartphone app development and evaluation of 6 new modules created in direct response to patients' expressed needs in complementary integration with the patient-centric care coordination model. The new modules are - My Coach, My Menu, My Fitness, My Accupressure, My Yoga and My Meditation. Population: IBD and other chronically ill patients.
$4 Million Gift from The Eli and Edythe Broad Foundation Benefits Research in Stem Cell Science and Digestive Diseases - May 2014
Yahoo! News, Westside Today, News-Medical, Century City/Westwood Patch, Examiner, Digital Journal, Stem Cell News, City News Service, WN News.com, Health Medicine Network, Pluripotent: Stem Cell News, and websites for FOX-TV (Greenville, N.C.),WVNS-TV (Ghent, Va.), WAND-TV (Decatur, Ill.), KWTV-TV (Oklahoma City, Okla.), WGFL-TV (Gainesville, Fla.), WFSB-TV (Hartford, Conn.), KVVU-TV (Las Vegas, Nev.), WFLX-TV (West Palm Beach, Fla.), KFDA-TV (Amarillo, Texas), KQCW-TV (Tulsa, Okla.), WAVE-TV (Louisville, Ky.) and others May 8, Bioresearch Online May 13 and Canyon News May 15 covered two gifts from The Eli and Edythe Broad Foundation to UCLA totaling $4 million that will fund UCLA research. The gifts will benefit the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and the Center for Inflammatory Bowel Diseases at UCLA's Division of Digestive Diseases. Dr. Owen Witte, director of the Broad Stem Cell Research Center and Dr. Gary Gitnick, professor and co-chief of the Division of Digestive Diseases, and the Fran and Ray Stark Foundation Chair at the David Geffen School of Medicine at UCLA, were quoted.
Value-Based Chronic Disease Care Management Awarded UCLA Innovation in Health Prize - November 2013
The UCLA Health Institute for Innovation held its first contest in November 2013. The purpose of the contest was to identify innovations that have been implemented in the past 18 months and have produced dramatic improvements at UCLA Health. There were 44 entries and over 330 team members that participated. Entries were from all parts of the health system including outpatient clinics, the Emergency Department, Environmental Services, Pharmacy, Interpreter Services, Human Resources, Quality, MITS, and many more. As part of this contest, UCLA Health employees were invited to participate in determining the semi-finalists by voting on the innovation they liked best. There were over 1,800 people that registered to vote. Seven semi-finalist teams were selected to move on for the final round of judging. The entries were then evaluated by an expert judge panel for impact on patient experience, quality, total cost of care, measures of success, ability to scale, and ease of implementation. On December 19 the winner of the Institute for Innovation in Health Contest was announced at the Innovation Gallery that showcased all the innovations that entered the contest. Team Value Quotient was recognized for their Value-Based Chronic Disease Care Management innovation.
Free UCLA eIBD App - 2012
The UCLA Center for Inflammatory Bowel Diseases is excited to announce our free UCLA eIBD app is live and available to all patients. Your home care and quality of life is managed 24/7 with our easily accessible smartphone app. You can actively manage your disease anywhere!
It's Like Having a Doctor in Your Back Pocket - November 2012
Southern California Physician magazine ran a story in their November 2012 issue on Telemedicine Redefined. Dr. Daniel Hommes, a professor of Medicine at UCLA, said, "Devices as the iPad can improve care while saving costs in the health care landscape of the future."
iPad Program at UCLA is Part of Effort to Provide Value-based Care for Patients - September 2012
eWeek ran a story on Sept. 21 about iPad Use at UCLA Helps Patients Manage Chronic Intestinal Ailments. Dr. Daniel Hommes, a professor of medicine at UCLA, told eWeek, "The idea is to have UCLA in your back pocket."
Trades Explore iPad Use in Patient Care - September 2012
Mobile Health News and Fierce Mobile Healthcare reported Sept. 18 that patients, doctors and specialized nurses at UCLA are all using Apple iPads to help track inflammatory bowel patients' symptoms and care and to communicate with each other in real-time about disease management. Dr. Daniel Hommes, professor of medicine and director of the UCLA Center for Inflammatory Bowel Diseases was quoted.